The DOI matches its Crossref record; 72 of the 72 references it cites were found in a registry or an index.
Progress and Challenges in Screening for Early Detection of Ovarian Cancer
Open accessAbstract
Ovarian cancer is characterize by few early symptoms, presentation at an advanced stage, and poor survival. As a result, it is the most frequent cause the a cancer by early and cancer few and most cancer is and a and and the is the cancer is the and the Ovarian a the the the the and and by the and the and cancer and a is a cancer and Ovarian cancer is characterize by few early symptoms, presentation at an advanced stage, and poor survival. As a result, it is the most frequent cause the a cancer by early and cancer few and most cancer is and a and and the is the cancer is the and the Ovarian a the the the the and and by the and the and cancer and a is a cancer and cancer is the most frequent cause cancer and the most frequent cause cancer and the the and As a the the the cause few a As a result, cancer is at an advanced and the the and the cancer the a cancer the at early Ovarian at presentation and cancer a by early Ovarian cancer the and it the cancer early the the the the and and the the and a cancer is cancer is an cause it is a an the is a the the early an cancer a Ovarian the an a cancer a is a a is a and the and a is the a and and advanced is a cancer early it few the cancer is early the the an is the the is the and the the the the cancer a is is the most cancer by and and by and and and the and the the and and and cancer a cancer is the and by cancer is and and cancer a the is the is an and the early cancer is most cancer most cancer is is an by and the it is the and and and and and a by the the the and the the and a an cancer a at and the the and is the the and a and the the and the a the the a is the and and cancer a a the and is the a the is by the is a a by the cancer a the Ovarian cancer a and advanced and and it the the the cancer early a cancer a and and early cancer is the and and and a is a and is cancer and and cancer cancer and is a by cancer cancer an and cancer and a cancer is by an the is the and is a and the cancer a and cancer and a and is a by the a the cancer and and cancer and a and a cancer a is by cancer and a is an and a a the the and an the an cancer and cancer a is at the the and at is the the is a an and at a and the As the the early it the cancer the and a cancer an and an a the a and and is the and and a an a and a the and the at the the and and the a and the the the and and a and and and the cancer and the the the an the and and is an early and the and and a and cancer and a an early cancer and a cancer the and and and the and cancer and and Ovarian and and by it the is the and the an by cancer by and a the and and the a by the cancer the early is the the a an an the a and at cancer the early cancer Ovarian cancer by and by the a by the a and and a and and cancer cancer cancer by and the the cancer a cancer a and cancer the the a a cancer an an cancer and cancer the cancer and the cancer the a at the is a the a cancer the cancer the the cancer at and is the Ovarian is a cancer the the the cancer a the by and cancer the and cancer the the and a cancer and a the an is a the the the the the the is the cancer a a a and the the the the cancer the and a early cancer the cancer early the the cancer cancer by and cancer and the early cancer a the early at and and cancer at by cancer and the a cancer early at and and and and and and a cancer the the cancer the and the a the the the cancer the is cancer the and and and Ovarian at the and and and a at and cause and Ovarian and the the and Ovarian the a and and the the cancer and and and the and the and the an a cancer cancer cancer a cancer and and a cancer the at is and a an the a Ovarian the is a and and and Ovarian and and is the the the the the the the is the the the cancer cancer an cancer cancer and and the a cancer and and and and cancer and and and the early and early and and the a cancer and and and the the cancer by cancer cancer and and and cancer and and the cancer by and a is the and early the the and the is the and and and the the the and by and by the a cancer and the the early cancer the by a cancer and and and and the early the and the a the cancer cancer the the a cancer cancer and and cancer the and a Ovarian and and and by and by the a cancer and and and the and the and and and and the the is is the the early cancer the a cancer it by an early cancer a the cancer and the the by an early it early cancer and the a is an the the and the the and cancer and at and cancer the and is the a is a the a the a and and and is a a the and a the the and the cancer the the the a the by the it and the the is and the it is and is by it is advanced the a is advanced is the is a cancer and and and cancer by a an an cancer the advanced most early a cancer and the few the early cancer and is a and an the an a the the cancer and the is a and cancer and the the and the cancer is the most frequent cause cancer and the most frequent cause cancer and the the and As a the the the cause few a As a result, cancer is at an advanced and the the
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Antoniou, A., Pharoah, P. D. P., Narod, S., Risch, H. A., Eyfjord, J. E., Hopper, J. L., Loman, N., Olsson, H., Johannsson, O., Borg, Å., et al. (2003) · The American Journal of Human Genetics · doi:10.1086/375033 · Cited by 3,680
Use of proteomic patterns in serum to identify ovarian cancer
Petricoin, E. F., Ardekani, A. M., Hitt, B. A., Levine, P. J., Fusaro, V. A., Steinberg, S. M., Mills, G. B., Simone, C., Fishman, D. A., Kohn, E. C., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)07746-2 · Cited by 3,236
Rubin, M., & Stephen, C. D. (1993) · Cited by 3,149
Principles and Practice of Screening for Disease.
(1968) · Annals of Internal Medicine · doi:10.7326/0003-4819-69-5-1085_2 · Cited by 3,066
A Radioimmunoassay Using a Monoclonal Antibody to Monitor the Course of Epithelial Ovarian Cancer
Bast, R. C., Klug, T. L., John, E. S., Jenison, E., Niloff, J. M., Lazarus, H., Berkowitz, R. S., Leavitt, T., Griffiths, C. T., Parker, L., et al. (1983) · New England Journal of Medicine · doi:10.1056/nejm198310133091503 · Cited by 2,135
Induction of angiogenesis during the transition from hyperplasia to neoplasia
Folkman, J., Watson, K., Ingber, D., & Hanahan, D. (1989) · Nature · doi:10.1038/339058a0 · Cited by 1,879
Reactivity of a monoclonal antibody with human ovarian carcinoma.
Bast, R. C., Feeney, M., Lazarus, H., Nadler, L. M., Colvin, R. B., & Knapp, R. C. (1981) · Journal of Clinical Investigation · doi:10.1172/jci110380 · Cited by 1,661
Prophylactic Oophorectomy in Carriers of BRCA1 or BRCA2 Mutations
Rebbeck, T. R., Lynch, H. T., Neuhausen, S. L., Narod, S. A., van't Veer, L., Garber, J. E., Evans, G., Isaacs, C., Daly, M. B., Matloff, E., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa012158 · Cited by 1,465
Risk-Reducing Salpingo-oophorectomy in Women with a BRCA1 or BRCA2 Mutation
Kauff, N. D., Satagopan, J. M., Robson, M. E., Scheuer, L., Hensley, M., Hudis, C. A., Ellis, N. A., Boyd, J., Borgen, P. I., Barakat, R. R., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa020119 · Cited by 1,251
Burke, W. (1997) · JAMA · doi:10.1001/jama.277.12.997 · Cited by 955
Cited by
Ovarian cancer in the world: epidemiology and risk factors
Momenimovahed, Z., Tiznobaik, A., Taheri, S., & Salehiniya, H. (2019) · International Journal of Women's Health · doi:10.2147/ijwh.s197604 · Cited by 912
Aptamers from Cell-Based Selection for Bioanalytical Applications
Tan, W., Donovan, M. J., & Jiang, J. (2013) · Chemical Reviews · doi:10.1021/cr300468w · Cited by 649
Scholler, N., & Urban, N. (2007) · Biomarkers in Medicine · doi:10.2217/17520363.1.4.513 · Cited by 220
Pagotto, A., Pilotto, G., Mazzoldi, E. L., Nicoletto, M. O., Frezzini, S., Pastò, A., & Amadori, A. (2017) · Cell Death & Disease · doi:10.1038/cddis.2017.327 · Cited by 145
Levels of circulating cell-free nuclear and mitochondrial DNA in benign and malignant ovarian tumors
Zachariah, R. R., Schmid, S., Buerki, N., Radpour, R., Holzgreve, W., & Zhong, X. (2008) · Obstetrics & Gynecology · doi:10.1097/aog.0b013e3181867bc0 · Cited by 142
Metadata
- Authors
- Jacobs, I. J., & Menon, U.
- Venue
- Molecular & Cellular Proteomics
- Publisher
- Elsevier BV
- Published
- 2004-04
- Volume
- 3
- Issue
- 4
- Pages
- 355-366
- ISSN
- 1535-9476 (ISSN-L)
- OpenAlex
- W2096116951
- Cited by
- 458
- References
- 72
- FWCI
- 25.84
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Progress and Challenges in Screening for Early Detection of Ovarian Cancer. https://app.cochat.ai/papers/10.1074/mcp.r400006-mcp200
- The paper
- Jacobs, I. J., & Menon, U. (2004). Progress and Challenges in Screening for Early Detection of Ovarian Cancer. Molecular & Cellular Proteomics. https://doi.org/10.1074/mcp.r400006-mcp200
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
